Restoring Brain
Physical Integrity.
“Redefining CNS recovery through high-purity lipid synthesis and Arrayán-Q™, our proprietary multi-channel genomic-guided stratification engine.”.
aiGEN Platform
Utilizing hybrid Long-Read sequencing to identify critical structural variants in Central Nervous System malignancies.
NVX-101
Clinical-grade Nervonic Acid formulations designed to restore the structural integrity of the myelin sheath.
Strategic Hub
Headquartered in Kendall Square, Cambridge, at the epicenter of the global biotechnology ecosystem.
Therapeutic Pipeline
Establishing US-based research infrastructure for NIH SBIR Phase I studies.
Latest Insights
Bridging the gap between genomics and clinical restoration.
March 2026
Closing the Gap: Why Structural Variation is the Next Frontier in Glioma Stratification
“Standard-of-care genomics in neuro-oncology has long relied on Short-Read Sequencing. However, SRS systematically fails to resolve complex chromosomal rearrangements…”
April 2026
ELOVL1 Polymorphisms: The Metabolic Bottleneck of CNS Repair
Exploring the genetic basis for variable response to Nervonic Acid supplementation and how Native Epigenomics preserves signals.